Unknown

Dataset Information

Long-term persistence with anti-osteoporosis drugs after fracture.


ABSTRACT:

Unlabelled

Long-term persistence with anti-osteoporosis drugs and determinants for discontinuation among fracture patients were examined. Persistence was 75.0 and 45.3 % after 1 and 5 years, respectively. Those aged ≥80 years were at increased risk of early discontinuation. Within 1 year after discontinuation, 24.3 % restarted therapy, yet 47.0 % persisted for 1 year.

Introduction

The risk of osteoporotic fracture can effectively be reduced with use of anti-osteoporosis drugs. However, little is known about persistence with these drugs after fracture where subsequent fracture risk is high. The aims were to determine long-term persistence with anti-osteoporosis drugs among fracture patients, including its determinants, and to describe restart and subsequent persistence.

Me

SUBMITTER: Klop C 

PROVIDER: S-EPMC4469296 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature